Safety and effectiveness of ferric carboxymaltose intravenous therapy in pediatric patients with chronic kidney disease

Iron-deficiency anemia is the most common reason for worsening of the anemia characteristically seen in chronic kidney disease (CKD). Ferric carboxymaltose (FCM) is a macromolecular hydroxide ferric carbohydrate complex that allows high-dose iron to be administered parenterally for gradual, controll...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Ortega, Patricia, Jimenez-Lozano, Ines, Cruz, Álejandro, Polo, Aurora Fernandez, Lopez, Mercedes, Ariceta, Gema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582777/
https://www.ncbi.nlm.nih.gov/pubmed/36275063
http://dx.doi.org/10.3389/fped.2022.967233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582777/
https://www.ncbi.nlm.nih.gov/pubmed/36275063
http://dx.doi.org/10.3389/fped.2022.967233

Ejemplares similares